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Introduction
Sexually transmitted diseases (STDs) including human 
immunodeficiency virus (HIV)/acquired immunodefi-
ciency syndrome (AIDS) present a huge threat globally, 
especially to women [1]. Women are biologically two 
times more likely than men to be infected by HIV via 
heterosexual intercourse. For example, after sexual inter-
course, semen remains within the female genital tract for 
prolonged periods of time, increasing exposure to HIV. In 
the absence of an effective vaccine, microbicides are being 
developed for vaginal and rectal application as a strategy 
to prevent and/or reduce sexual transmission of HIV. The 
emergence of microbicides has greatly improved the feasi-
bility for women to protect themselves because the use of 
microbicides is discreet without requiring co-operation or 
consent by their sexual partners [2, 3]. Microbicides have 
been formulated into various dosage forms including gels, 
films, tablets, and vaginal rings [4–6]. The active microbi-
cidal agent can vary from small molecule drugs [7] to large 
biomacromolecules such as peptides and proteins [8]. Pep-
tides, as a class of anti-microbicidal agents, have gained 
extensive attention recently due to their highlighted proper-
ties such as their broad anti-microbial and immunomodula-
tory effects in comparison to chemical agents [9, 10].
However, the lack of reliable and rapid quantification 
methods for this class of microbicides presents as a great 
inconvenience to their researchers, especially analysts. 
Although there are several existing methods for protein/
peptide quantification such as spectrophotometry, western 
blot, and enzyme-linked immunosorbent assay (ELISA), 
their individual limitations hinder them from satisfying 
the needs of practical applications. For example, the com-
mercially available BCA/Bradford assay based on spectro-
photometry lacks specificity and sensitivity. These assays 
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cannot distinguish between different proteins/peptides, 
and the lower limit of quantification (LLOQ) for the BCA 
assay that can be achieved without interference is approxi-
mately 1.23 µg mL−1 [11]. Furthermore, the accuracy of 
these assays are significantly reduced when approaching 
the LLOQ and the results can be inconsistent due to inter-
ference by impurities or the presence of other substances, 
e.g., excess salts, surfactants, polymers, etc. [11].Western 
blot has good specificity in identifying the target protein/
peptide. It is a semi-quantitative method and is time-con-
suming, especially for the detection of small peptides due to 
the much higher degree of cross-linked gel matrix required, 
thus resulting in significantly longer electrophoresis run-
time. ELISA is a reliable method with both specificity and 
accuracy, but the sample analysis is generally time-consum-
ing requiring optimization of appropriate antibody/antigen 
incubation and can be expensive due to the need of antibod-
ies with high specificity, thereby affecting its efficiency for 
analyzing large quantities of pharmaceutical samples. In 
contrast, reversed-phase high-performance liquid chroma-
tography (RP-HPLC) has good precision (<2 %), accept-
able selectivity and sensitivity (as low as 0.33 μg mL−1), 
relatively inexpensive (e.g., does not require the use of anti-
bodies) and is less time-consuming than traditional protein 
analysis methods (e.g., gel electrophoresis) [11, 12].
In the current study, our group has developed a rapid 
and sensitive RP-HPLC quantification method for two 
peptides, gp120 fragment (encompassing the CD4 binding 
site) and LL-37, with potential applications in microbicide 
development. To the best of our knowledge, this is the first 
paper focusing on developing an accurate, rapid, robust 
and convenient analysis method that can be used to analyze 
these microbicidal peptides in polymeric gel formulations. 
LL-37 is the only cathelicidin host defense peptide found in 
humans [13, 14]. LL-37 has been shown to exhibit antibac-
terial [15], anti-fungal [16], anti-viral [17, 18], wound heal-
ing [19, 20], anticancer [21, 22], and immunomodulatory 
activity [23]. Glycoprotein 120 (gp120) is part of the HIV 
envelope protein and its fragment (target analyte in current 
study) has been used for the induction of anti-HIV neutrali-
zation antibodies [24, 25]. Although there are published lit-
eratures reporting the use of RP-HPLC for the purification 
of LL-37 [26, 27], to the best of our knowledge, there is 
no validated RP-HPLC method for determining the con-
centration of LL-37 or gp120 fragment alone or simultane-
ously. The current study is the first to apply a validated RP-
HPLC method for the simultaneous quantification of LL-37 
and gp120 fragment in polymeric gel dosage forms. Since 
peptides are generally unstable under certain environmen-
tal conditions resulting in degradation and/or aggregation, 
we further evaluated the application of the current RP-
HPLC method for identifying the degradation or aggrega-
tion products of both peptides. This method is rapid, robust 




Water and acetonitrile (HPLC grade) were purchased from 
EMD (Mississauga, ON, Canada). LL-37 (4,493.33 Da, 
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES) 
and gp120 fragment (2,138.56 Da, KQFINMWQEVG-
KAMYAPP) were custom synthesized by CPC Scientific 
Inc. (Sunnyvale, CA, USA) and Biomatik Corp. (Cam-
bridge, ON, Canada), respectively. Hydroxyethylcellulose 
(HEC) (Natrosol™, 250 HX PHARM) was a kind gift 
from Ashland Inc. (Covington, KY, USA). Hydroxypropyl 
methylcellulose (HPMC, Methocel E4 M Premium) was 
kindly supplied by The Dow Chemical Company (Cal-
gary, Alberta, Canada) and hydroxypropyl cellulose (HPC) 
(4,000–6,500 cps) was purchased from Spectrum Chemical 
Manufacturing Corp. (New Brunswick, NJ, USA). Glyc-
erol, trifluoroacetic acid (TFA), acetic acid and dipotassium 
phosphate were purchased from Fisher Scientific (Ottawa, 
ON, Canada).
RP-HPLC Method
Stock solutions of both peptides (1 mg mL−1) were pre-
pared in water. Working standard solutions were prepared 
from the stock solutions covering the range of 0.625–
80 µg mL−1 (n = 6). Quantification of gp120 fragment and 
LL-37 was performed using a gradient RP-HPLC method. 
Analysis was performed using a XBridge™ BEH300 C18 
column (300 Å, 5 µm 4.6 × 150 mm; Waters) with a Sym-
metry C18 guard column (300 Å, 5 µm, 3.9 × 20 mm; 
Waters), fitted to a Waters® Alliance® HPLC system 
equipped with Waters® 2690 Separations module and 
Waters® 996 Photodiode Array detector. Mobile phase 
A consisted of 0.1 % TFA in 10 % acetonitrile in HPLC 
grade water. Mobile phase B consisted of 0.85 % TFA in 
90 % acetonitrile in water. A gradient A/B was applied to 
elute and analyze the peptides: A/B from 85:15 to 20:80 in 
6 min, followed by maintaining at 20:80 for 2 min and re-
equilibration of the column at 85:15. Total run was 10 min 
for each 200 μL injection. Flow rate was 2.0 mL min−1, 
UV detection was set at 210 nm, and column temperature 
was maintained at 60 °C. The retention time for gp120 
and LL-37 were approximately 2.7 min and 4.1 min, 
respectively. The linear calibration curves for gp120 and 
LL-37 were obtained in the range of 0.625–80 µg mL−1 
(R2 > 0.999) and 1.25–80 µg mL−1 (R2 > 0.999), respec-
tively (n = 6).
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Preparation and Extraction of LL-37/gp120 
from Polymeric Microbicide Gels
Approximately 1 g of HEC, HPMC, or HPC (2 %) was 
added to 40 mL of KH2PO4 (pH 7.4) and stirred at 4 °C 
for 2 h until dissolved. To adjust the viscosity of the gel 
to be similar to gels used for microbicide evaluation (e.g., 
~2,736 cP) [28], 5 g of glycerol (10 %) was added and 
stirred until it was uniformly dispersed. Water was used to 
dissolve gp120 and 20 % acetic acid was used to dissolve 
LL-37 to make a concentration of 1 mg mL−1. Each pep-
tide was mixed with the gels at a weight ratio of 1:1:4,000 
(gp120:LL-37:gel) and stirred at 4 °C for 2 h resulting in 
a preparation containing 1 % HEC, HPMC, or HPC gel 
loaded with gp120 (0.025 %, w/w) and LL-37 (0.025 %, 
w/w).
For the extraction of peptides from polymeric gels, 
approximately 200 mg of the gel was weighed into a 
5-mL volumetric flask and filled to volume with HPLC 
grade water. The sample was vortexed at room tempera-
ture for 30 s (three runs of 10 s each) and sonicated on 
ice for another 20 s (two runs of 10 s each). The extrac-
tion samples were then analyzed on RP-HPLC. To deter-
mine the extraction efficiency (assayed peptide concentra-
tion in the gel divided by the theoretical concentration in 
the gel), blank gels were spiked with known amounts of 
gp120 and LL-37 followed by the extraction procedure as 
described above.
Forced Heat-Stress Studies
Both gp120 and LL-37 were exposed to various environ-
mental conditions to force degrade the peptides. Since 
these peptides may be used for microbicide development, 
vaginal fluid simulant (VFS; 60 mM NaCl, 25 mM KOH, 
3 mM Ca(OH)2, 6.6 mM urea, 28 mM glucose, 22 mM 
lactic acid, 16.7 mM acetic acid, 1.7 mM glycerol, pH 
4.2) [29] was used for the stability studies. Both peptides 
were freshly dissolved in VFS separately to yield a 1 mg 
mL−1 solution. Aliquots of both peptides (200 µL) were 
then heat-stressed using a heating block at 95 °C for up to 
8 h. The samples were then allowed to cool down to room 
temperature and stored at −20 °C prior to analysis. Non-
heat-stressed samples were immediately stored at −20 °C 
after dissolving the peptides. The collected samples 
were analyzed either using the same RP-HPLC method 
described above or using tris-tricine SDS-PAGE [30]. For 
tris-tricine SDS-PAGE, stressed and non-stressed pep-
tides (10 µg) were mixed with 5 µL of 3× sample load-
ing buffer without 2-mercaptoethanol and loaded on to a 
tris-tricine gel, containing a stacking gel (4 % T, 3 % C, 
which T is for total acrylamide concentration and C is for 
crosslinker concentration), spacer gel (10 % T, 6 % C), 
and a separating gel (16 % T, 6 % C). Electrophoresis 
was performed at room temperature with an initial volt-
age of 30 V until the samples completely migrated into 
the spacer gel, followed by four incremental increases in 
voltage (15 V per increment) to a final voltage of 90 V 
until the tracking dye reached the bottom of the gel. After 
5 h of electrophoresis, resolved peptides and their deg-
radation/aggregation products were visualized using a 
rapid Coomassie Blue R-250 staining method [31]. Target 
degradation/aggregation peptide bands were then care-
fully cut from the gels and recovered by electro-elution. 
Briefly, gel slices containing the aggregation bands of 
interest (combined from 6 to 8 gels to increase recov-
ery) were encased in a Spectra/Por® Micro Float-A-Lyzer 
dialysis device (0.5–1 kDa MWCO Spectrum Laborato-
ries, Inc., Compton, CA, USA) and immersed in transfer 
buffer (25 mM tris, 192 mM glycine, 20 % methanol v/v, 
pH 8.3). Electro-elution was conducted at 100 V for 1.5 h 
to ensure complete migration of peptide samples out of 
the gel matrix. After overnight dialysis against PBS (pH 
7.4) at 4 °C to remove residual SDS, samples were freeze-
dried using a benchtop freeze dry system (Labconco® 
FreeZone 2.5 Liter). Lyophilized peptides and their aggre-
gation products were re-solubilized in 250 µL double dis-
tilled water and immediately subjected to RP-HPLC anal-
ysis. Heat-stressed peptides were then used to spike HPC, 
HPMC, and HEC gels, and peptide extraction/RP-HPLC 
analysis was performed as described earlier.
Statistical Analysis
Data are expressed as the mean ± standard deviation (SD) 
from the obtained results. Student’s t test was performed 
using GraphPad Prism version 6.0c (GraphPad Software, 




Linearity was determined from a calibration curve using 
standards of gp120 and LL-37 solutions in the range of 
0.625–80 μg mL−1 in water and with six replicates. Linear 
relationship was observed between the peak area and the 
concentrations of peptides in water as reported in Table 1 
with a regression coefficient of 0.999. The lower limit of 
detection (LLOD) and LLOQ were obtained as defined 
by the International Conference on Harmonisation (ICH) 
Topic Q2B [32] using the slope (b) of the calibration curve 
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and the standard deviation, Sa, of the intercept (a) using the 
equations below:
Accuracy values were determined via the following 
equation and were always within the acceptable limits 
(±5 %) at all validation concentrations (Table 1).
Precision was determined from three standard calibration 
curves. Two were from the same day for intra-day precision 
and the third one was from a different day for inter-day preci-
sion. Intra- and inter-day precision was evaluated by analyzing 
both peptides at low (5 μL mL−1), medium (15 μL mL−1), 
and high (40 μL mL−1) concentrations (n = 6, Table 1). The 
relative standard deviation (%RSD) values were calculated for 
each concentration. The precision was found to be acceptable 
(<5 %), with the %RSD values of intra-day precision ranging 
0.28–1.27 % for gp120 and 0.85–1.45 % for LL-37 as well 
as the %RSD values of inter-day precision ranging 0.23–
0.47 % for gp120 and 0.21–0.87 % for LL-37. The determined 
LLOD and LLOQ for gp120 were 0.10 and 0.31 μL mL−1, 










respectively. The assayed accuracy for the lower concentra-
tions approaching the LLOQ of gp120 fragment (at 0.625 μg 
mL−1) and LL-37 (at 1.25 μg mL−1) were 114.5 ± 7.5 % and 
115.5 ± 0.09 %, respectively (n = 3).
Peptide Extraction from Gels and Peptide Separation 
by RP-HPLC Method
To evaluate whether current RP-HPLC method was suitable for 
the quantification of both peptides within polymeric matrices, 
this method was applied towards the extraction of both gp120 
fragment and LL-37 simultaneously from HEC, HPMC, and 
HPC gels. Results showed that both peptides were success-
fully extracted from all polymeric gels with high extraction 
efficiency ranging from 95.90 ± 3.03 to 106.33 ± 2.46 % for 
gp120 fragment and from 98.27 ± 2.51 to 111.45 ± 2.51 % 
for LL-37, respectively (Table 2). The loadings of both pep-
tides in the polymeric gel formulations were found in the range 
0.0236–0.0241 % for gp120 fragment and 0.0238–0.0248 % 
for LL-37 using the current extraction procedure (Table 2).
Identification of gp120 Fragment and LL-37 Degradation/
Aggregation Products
Using the current validated method that was developed 
for quantitating gp120 fragment and LL-37, separation of 
heat-stressed peptides under acidic exposure was achieved 
(Fig. 2a, b). There were two distinct gp120 fragment 
Table 1  Method validation of RP-HPLC for gp120 fragment and LL-37
R regression coefficient, LLOD lower limit of detection, LLOQ lower limit of quantification
Conc.  
(μg mL−1 )




Intra-day Inter-day Intra-day Inter-day Intra-day Inter-day
gp120
 5 0.999 Y = 97,794.50  
(± 1,128.59) × 
 X + 8,627.98  
(± 3,050.39)
4.84 ± 0.12 5.02 ± 0.10 1.27 0.47 96.38 100.4 0.10 0.31
 15 14.97 ± 0.32 15.04 ± 0.33 0.28 0.23 100.36 100.5
 40 40.02 ± 0.17 39.93 ± 0.47 0.37 0.43 99.87 99.87
LL-37
 5 0.999 Y = 64,831.25  
(± 682.50) ×  
X + 14,115.90  
(± 7,384.79)
4.91 ± 0.42 5.02 ± 0.31 1.45 0.87 95.67 98.97 0.38 1.14
 10 15.05 ± 0.37 15.01 ± 0.28 0.93 0.88 97.45 98.45
 40 39.93 ± 0.26 40.04 ± 0.32 0.82 0.21 97.23 100.23
Table 2  Extraction of gp120 fragment and LL-37 from different polymeric gels
Data represent mean ± SD, n = 6
 EE extraction efficiency (%)
Type of gels EE of gp120 (%) Concentration of gp120 (w/w, %) EE of LL-37 (%) Concentration of LL-37 (w/w, %)
1 % HEC gel 95.90 ± 3.03 0.0241 ± 0.0008 98.27 ± 2.51 0.0240 ± 0.0008
1 % HPMC gel 106.33 ± 2.46 0.0236 ± 0.0006 105.66 ± 3.16 0.0238 ± 0.0004
1 % HPC gel 101.07 ± 4.02 0.0241 ± 0.0001 111.45 ± 2.51 0.0248 ± 0.0005
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Fig. 1  Extraction of gp120 fragment and LL-37 from polymeric 
gels. Chromatograms of gp120 fragment and LL-37 before and after 
extraction from a HPC, b HEC and c HPMC gels via the current RP-
HPLC method. Each representative chromatogram was obtained from 
repetitive RP-HPLC analysis (n = 6)
Fig. 2  Overlay chromatograms of forced degraded peptides. RP-
HPLC overlay chromatograms showing the detection and separa-
tion of heat-stressed gp120 fragment alone (a heat-stressed up to 
8 h), LL-37 alone (b heat-stressed up to 8 h), both gp120 fragment 
and LL-37 analyzed simultaneously comparing to individual peptide 
chromatograms (c heat-stressed for 5 h, spiked into HEC gel) using 
RP-HPLC. Peaks G1 and G2 represent the force-degraded peaks of 
gp120 fragment while peaks L1–3 represent LL-37 forced degraded 
product peaks. The representative chromatogram demonstrated was 
obtained from repetitive measurements with polymeric gels spiked 
with both peptides (n = 3)
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degradants and three LL-37 degradants identified using the 
current RP-HPLC method (Fig. 2a, b). The induced gp120 
fragment degradants were found to have retention times of 
approximately 2.2 min (G1) and 3.2 min (G2) while LL-37 
degradants with retention time of 2.9 min (L1), 4.4 min 
(L2), and 4.7 min (L3). It was also shown in Fig. 2c that the 
current method could successfully separate all identified 
forced degradants from gp120 fragment and LL-37 peaks 
in the presence of polymers. However, prolonged exposure 
to stressed conditions (>5 h) resulted in a decrease and/
or absence of peaks for gp120 fragment, LL-37, and their 
forced degraded products (Figs. 2a, c, 3). Further identifi-
cation of LL-37 forced degraded products revealed that L2 
and L3 were approximately 12 and 16 kDa, respectively 
(Fig. 3a, b).
Discussion
In the current study, we have developed an accurate and 
precise RP-HPLC method with validation for quantitating 
two peptides simultaneously, gp120 fragment and LL-37, 
formulated in three polymeric hydrophilic gel formulations 
with acceptable reproducibility. According to the chroma-
tograms, there was little to no interference caused by the 
polymeric gels using the current RP-HPLC method with 
respect to peak shape and peak area (Fig. 1). This could be 
attributed to the hydrophilic property of the polymers tested 
in the current study resulting in negligible interactions 
with the analytical column [11]. In RP-HPLC, hydropho-
bic molecules (in current study, the two peptides) are first 
adsorbed onto the hydrophobic stationary phase (e.g., C18 
column) in a polar mobile phase and can be later eluted 
by decreasing the polarity of the mobile phase through the 
introduction of acetonitrile [11]. Furthermore, our gradi-
ent method was capable of simultaneously separating both 
peptides without any overlap in peaks (Fig. 1). LL-37 and 
gp120 fragment exhibit different hydrophobicities with an 
estimated relative hydrophobicity value of 52.62 and 42.16, 
respectively, as predicated by the current algorithm SSR-
Calc prediction model (http://hs2.proteome.ca/SSRCalc/
SSRCalcX.html, using a 300 Å C18 column in 0.1 % TFA) 
[33]. This prediction model takes into consideration various 
parameters which may influence peptide behavior such as 
amino acid composition, the nature of N- and C-terminal 
residues, peptide length, and pI, etc. [34].Thus, the slightly 
higher relative hydrophobicity of LL-37 may explain the 
later elution of this peptide compared to gp120 fragment 
(Fig. 1).
Since microbicides are usually applied topically to the 
vagina, peptides formulated in a polymeric pharmaceutical 
dosage needs to be stable within their surrounding environ-
ment, e.g., the physiological temperature of the female gen-
ital tract is 37 °C and vaginal fluid is acidic (pH 3.5–4.9) 
[29]. These conditions may potentially increase the degra-
dation rate of proteins and peptides [29]. Thus, we further 
evaluated the utility of the current RP-HPLC method to: (1) 
distinguish forced degradation products of both peptides 
and (2) quantitate the residual peptides within the poly-
meric gels without any interference. Under forced degra-
dative conditions for up to 8 h (95 °C in pH 4.2 buffer), 
the current method was able to differentiate between the 
degraded products for gp120 (G1–2) and LL-37 (L1–3) 
(Fig. 2), and was successful in separating the peptide peaks 
while in the presence of all three polymers (Fig. 2c, a rep-
resentative spiked HEC gel analysis was presented and 
similar chromatograms were observed using HPC and 
HPMC gels). These observations were supported by the 
Fig. 3  Gel electrophoresis and RP-HPLC detection of forced 
degraded products. Tris-tricine SDS-PAGE of heat-stressed gp120 
fragment and LL-37 samples (a) and the overlay chromatogram 
of LL-37 forced degraded products (b). Lane 1 MW markers; lane 
2 LL-37 non-stressed; lanes 3–5 LL-37 heat-stressed for 2, 5, 8 h; 
lane 6 gp120 fragment non-stressed; lanes 7–9 gp120 fragment heat-
stressed for 2, 5, 8 h. Force-degraded bands (L2 and L3) of LL-37 
were extracted from the gel and analyzed using RP-HPLC. Each rep-
resentative chromatogram was obtained from repeated gel electropho-
resis (n = 3) and RP-HPLC analysis (n = 3)
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tris-tricine SDS-PAGE results (Fig. 3a). Moreover, the cur-
rent RP-HPLC method was able to identify and differenti-
ate the forced degraded products, which cannot be detected 
by tris-tricine SDS-PAGE, e.g., products G1, G2, and L1 
(Fig. 2). The absent peaks of gp120 fragment, LL-37, and 
their degradation products after prolonged (>5 h) heat/
acid exposure (Fig. 2a, b) could be attributed to the severe 
degree of hydrolytic cleavage (breaking down into amino 
acids) of both peptides and the degradants [35, 36].
Conclusions
In the current study, we developed a fast, accurate, and 
reliable RP-HPLC method for the quantitation of two can-
didate microbicide peptides, LL-37 and gp120 fragment 
simultaneously in polymeric gel formulations. This method 
was able to detect and separate the forced degraded prod-
ucts of both peptides simultaneously in the presence of pol-
ymers without any interference or affecting the determina-
tion of peptide concentration, providing a quick and precise 
alternative to LC–MS techniques.
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